Cargando…

Do nanoparticles provide a new opportunity for diagnosis of distal airspace disease?

There is a need for efficient techniques to assess abnormalities in the peripheral regions of the lungs, for example, for diagnosis of pulmonary emphysema. Considerable scientific efforts have been directed toward measuring lung morphology by studying recovery of inhaled micron-sized aerosol particl...

Descripción completa

Detalles Bibliográficos
Autores principales: Löndahl, Jakob, Jakobsson, Jonas KF, Broday, David M, Aaltonen, H Laura, Wollmer, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5191892/
https://www.ncbi.nlm.nih.gov/pubmed/28053522
http://dx.doi.org/10.2147/IJN.S121369
_version_ 1782487706244218880
author Löndahl, Jakob
Jakobsson, Jonas KF
Broday, David M
Aaltonen, H Laura
Wollmer, Per
author_facet Löndahl, Jakob
Jakobsson, Jonas KF
Broday, David M
Aaltonen, H Laura
Wollmer, Per
author_sort Löndahl, Jakob
collection PubMed
description There is a need for efficient techniques to assess abnormalities in the peripheral regions of the lungs, for example, for diagnosis of pulmonary emphysema. Considerable scientific efforts have been directed toward measuring lung morphology by studying recovery of inhaled micron-sized aerosol particles (0.4–1.5 µm). In contrast, it is suggested that the recovery of inhaled airborne nanoparticles may be more useful for diagnosis. The objective of this work is to provide a theoretical background for the use of nanoparticles in measuring lung morphology and to assess their applicability based on a review of the literature. Using nanoparticles for studying distal airspace dimensions is shown to have several advantages over other aerosol-based methods. 1) Nanoparticles deposit almost exclusively by diffusion, which allows a simpler breathing maneuver with minor artifacts from particle losses in the oropharyngeal and upper airways. 2) A higher breathing flow rate can be utilized, making it possible to rapidly inhale from residual volume to total lung capacity (TLC), thereby eliminating the need to determine the TLC before measurement. 3) Recent studies indicate better penetration of nanoparticles than micron-sized particles into poorly ventilated and diseased regions of the lungs; thus, a stronger signal from the abnormal parts is expected. 4) Changes in airspace dimensions have a larger impact on the recovery of nanoparticles. Compared to current diagnostic techniques with high specificity for morphometric changes of the lungs, computed tomography and magnetic resonance imaging with hyperpolarized gases, an aerosol-based method is likely to be less time consuming, considerably cheaper, simpler to use, and easier to interpret (providing a single value rather than an image that has to be analyzed). Compared to diagnosis by carbon monoxide (D(L,CO)), the uptake of nanoparticles in the lung is not affected by blood flow, hemoglobin concentration or alterations of the alveolar membranes, but relies only on lung morphology.
format Online
Article
Text
id pubmed-5191892
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-51918922017-01-04 Do nanoparticles provide a new opportunity for diagnosis of distal airspace disease? Löndahl, Jakob Jakobsson, Jonas KF Broday, David M Aaltonen, H Laura Wollmer, Per Int J Nanomedicine Hypothesis There is a need for efficient techniques to assess abnormalities in the peripheral regions of the lungs, for example, for diagnosis of pulmonary emphysema. Considerable scientific efforts have been directed toward measuring lung morphology by studying recovery of inhaled micron-sized aerosol particles (0.4–1.5 µm). In contrast, it is suggested that the recovery of inhaled airborne nanoparticles may be more useful for diagnosis. The objective of this work is to provide a theoretical background for the use of nanoparticles in measuring lung morphology and to assess their applicability based on a review of the literature. Using nanoparticles for studying distal airspace dimensions is shown to have several advantages over other aerosol-based methods. 1) Nanoparticles deposit almost exclusively by diffusion, which allows a simpler breathing maneuver with minor artifacts from particle losses in the oropharyngeal and upper airways. 2) A higher breathing flow rate can be utilized, making it possible to rapidly inhale from residual volume to total lung capacity (TLC), thereby eliminating the need to determine the TLC before measurement. 3) Recent studies indicate better penetration of nanoparticles than micron-sized particles into poorly ventilated and diseased regions of the lungs; thus, a stronger signal from the abnormal parts is expected. 4) Changes in airspace dimensions have a larger impact on the recovery of nanoparticles. Compared to current diagnostic techniques with high specificity for morphometric changes of the lungs, computed tomography and magnetic resonance imaging with hyperpolarized gases, an aerosol-based method is likely to be less time consuming, considerably cheaper, simpler to use, and easier to interpret (providing a single value rather than an image that has to be analyzed). Compared to diagnosis by carbon monoxide (D(L,CO)), the uptake of nanoparticles in the lung is not affected by blood flow, hemoglobin concentration or alterations of the alveolar membranes, but relies only on lung morphology. Dove Medical Press 2016-12-19 /pmc/articles/PMC5191892/ /pubmed/28053522 http://dx.doi.org/10.2147/IJN.S121369 Text en © 2017 Löndahl et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Hypothesis
Löndahl, Jakob
Jakobsson, Jonas KF
Broday, David M
Aaltonen, H Laura
Wollmer, Per
Do nanoparticles provide a new opportunity for diagnosis of distal airspace disease?
title Do nanoparticles provide a new opportunity for diagnosis of distal airspace disease?
title_full Do nanoparticles provide a new opportunity for diagnosis of distal airspace disease?
title_fullStr Do nanoparticles provide a new opportunity for diagnosis of distal airspace disease?
title_full_unstemmed Do nanoparticles provide a new opportunity for diagnosis of distal airspace disease?
title_short Do nanoparticles provide a new opportunity for diagnosis of distal airspace disease?
title_sort do nanoparticles provide a new opportunity for diagnosis of distal airspace disease?
topic Hypothesis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5191892/
https://www.ncbi.nlm.nih.gov/pubmed/28053522
http://dx.doi.org/10.2147/IJN.S121369
work_keys_str_mv AT londahljakob donanoparticlesprovideanewopportunityfordiagnosisofdistalairspacedisease
AT jakobssonjonaskf donanoparticlesprovideanewopportunityfordiagnosisofdistalairspacedisease
AT brodaydavidm donanoparticlesprovideanewopportunityfordiagnosisofdistalairspacedisease
AT aaltonenhlaura donanoparticlesprovideanewopportunityfordiagnosisofdistalairspacedisease
AT wollmerper donanoparticlesprovideanewopportunityfordiagnosisofdistalairspacedisease